Back to Search
CHARLES BUSER, M.D.
M.D.
Family Medicine Physician
NPI: 1366736373IndividualAccepts Medicare
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training Program
Student in an Organized Health Care Education/Training Program
Code: 390200000X
PG155510(OR)
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
MD164784(OR)
CMS Specialties
PrimaryFAMILY PRACTICE
Education
OREGON HEALTH SCIENCES UNIVERSITY SCHOOL OF MEDICINE
Class of 2011
Research & Publications (20)
High-performance liquid chromatography/mass spectrometry characterization of Ki4B-Ras in PSN-1 cells treated with the prenyltransferase inhibitor L-778,123.
PMID 11180946·Anal Biochem·2001
8-other
Major tegument protein pp65 of human cytomegalovirus is required for the incorporation of pUL69 and pUL97 into the virus particle and for viral growth in macrophages.
PMID 19116255·J Virol·2009
8-other
Inverse thermodilution with conventional pulmonary artery catheters for the assessment of cerebral, hepatic, renal, and femoral blood flow.
PMID 19033887·Shock·2009
7-preclinical
Development of thioquinazolinones, allosteric Chk1 kinase inhibitors.
PMID 19155174·Bioorg Med Chem Lett·2009
8-other
Characterization of inhibitor binding to human kinesin spindle protein by site-directed mutagenesis.
PMID 19467625·Arch Biochem Biophys·2009
8-other
Kinesin spindle protein (KSP) inhibitors. 9. Discovery of (2S)-4-(2,5-difluorophenyl)-n-[(3R,4S)-3-fluoro-1-methylpiperidin-4-yl]-2-(hydroxymethyl)-N-methyl-2-phenyl-2,5-dihydro-1H-pyrrole-1-carboxamide (MK-0731) for the treatment of taxane-refractory cancer.
PMID 18578472·J Med Chem·2008
8-other
Freeze-substitution: the addition of water to polar solvents enhances the retention of structure and acts at temperatures around -60 degrees C.
PMID 18445157·J Microsc·2008
7-preclinical
Cotreatment with vorinostat enhances activity of MK-0457 (VX-680) against acute and chronic myelogenous leukemia cells.
PMID 18829489·Clin Cancer Res·2008
7-preclinical
Discovery and biochemical characterization of selective ATP competitive inhibitors of the human mitotic kinesin KSP.
PMID 17999913·Arch Biochem Biophys·2008
8-other
Optimization of a pyrazoloquinolinone class of Chk1 kinase inhibitors.
PMID 17804227·Bioorg Med Chem Lett·2007
8-other
Kinesin spindle protein (KSP) inhibitors. Part 7: Design and synthesis of 3,3-disubstituted dihydropyrazolobenzoxazines as potent inhibitors of the mitotic kinesin KSP.
PMID 17804233·Bioorg Med Chem Lett·2007
7-preclinical
Synthesis and evaluation of substituted benzoisoquinolinones as potent inhibitors of Chk1 kinase.
PMID 17900896·Bioorg Med Chem Lett·2007
8-other
Kinesin spindle protein (KSP) inhibitors. Part 8: Design and synthesis of 1,4-diaryl-4,5-dihydropyrazoles as potent inhibitors of the mitotic kinesin KSP.
PMID 17766111·Bioorg Med Chem Lett·2007
8-other
Cytomegalovirus primary envelopment occurs at large infoldings of the inner nuclear membrane.
PMID 17192309·J Virol·2007
7-preclinical
Random screening for dominant-negative mutants of the cytomegalovirus nuclear egress protein M50.
PMID 17376929·J Virol·2007
7-preclinical
Kinesin spindle protein (KSP) inhibitors. Part V: discovery of 2-propylamino-2,4-diaryl-2,5-dihydropyrroles as potent, water-soluble KSP inhibitors, and modulation of their basicity by beta-fluorination to overcome cellular efflux by P-glycoprotein.
PMID 17395460·Bioorg Med Chem Lett·2007
8-other
Cytomegalovirus primary envelopment at large nuclear membrane infoldings: what's new?
PMID 17567708·J Virol·2007
7-preclinical
Kinesin spindle protein (KSP) inhibitors. Part 6: Design and synthesis of 3,5-diaryl-4,5-dihydropyrazole amides as potent inhibitors of the mitotic kinesin KSP.
PMID 17761419·Bioorg Med Chem Lett·2007
8-other
Quantitative investigation of murine cytomegalovirus nucleocapsid interaction.
PMID 17910700·J Microsc·2007
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1021 JUNE ST
HOOD RIVER, OR 97031 - Phone
- (541) 386-2204
Quick Facts
- NPI
- 1366736373
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 15
- Publications
- 20
Are you this provider?
Claim Your Profile